The company says its ANSWER platform fixes what undid first-generation allogeneic CAR-T, and is pursuing T-cell leukemia and ...
Pritam International used color additive identified as “CI 14720,” also known as Ext. D&C Red No. 10, Acid Red No. 14, Food ...
Edwards touted PROGRESS data showing SAPIEN 3 TAVR cut heart failure events in moderate AS, while EARLY TAVR economics showed ...
Former Madrigal exec Michael Charlton has filed suit against the firm alleging that he was forced out after raising concerns ...
AbbVie VP-global head of immunology clinical development Kori Wallace talked to Scrip about what could be the company’s next ...
The EMA could extend its product development coordinator model to medicines outside PRIME after completing a two-year pilot ...
Sean Keveney agreed to stay in the job until a successor is found and a transition is completed, but he could be one of ...
The UK’s pilot of voluntary clinical trial diversity plans will expand in early 2027, after commercial sponsors reported ...
Competitive pressure is hitting Bayer’s Nutritionals business, with US multivitamins especially tough, the company told HBW ...
Drug developers could get a faster way to put focused scientific questions to the European Medicines Agency, as the regulator ...
Ultragenyx will cut about a fifth of its staff and drop its Wilson disease gene therapy to reach profitability in 2027 as it ...
Novo has upgraded its full-year forecast thanks to the huge success of the Wegovy pill, but analysts want to see more action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results